Pain Assessment Tools in Palliative Cancer Care
暂无分享,去创建一个
[1] P. Stone,et al. Evidence-based guidelines for the use of opioid analgesics in the treatment of cancer pain: The 2011 EAPC Recommendations. , 2012 .
[2] J. Farrar,et al. Expert conference on cancer pain assessment and classification—the need for international consensus: working proposals on international standards , 2011, BMJ Supportive & Palliative Care.
[3] Nicholas A. Christakis,et al. Oxford Textbook of Palliative Medicine , 2011 .
[4] P. Fayers,et al. The dimensionality of pain: Palliative care and chronic pain patients differ in their reports of pain intensity and pain interference , 2011, PAIN®.
[5] Augusto Caraceni,et al. Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. , 2011, Journal of pain and symptom management.
[6] M. Bennett,et al. Neuropathic pain features in patients with bone metastases referred for palliative radiotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] E. Bruera,et al. An international multicentre validation study of a pain classification system for cancer patients. , 2010, European journal of cancer.
[8] S. Kaasa. An international multicentre validation study of a pain classification system for cancer patients. , 2010, European journal of cancer.
[9] S. Mercadante,et al. Breakthrough pain in oncology: a longitudinal study. , 2010, Journal of pain and symptom management.
[10] G. Cruccu,et al. EFNS guidelines on neuropathic pain assessment: revised 2009 , 2010, European journal of neurology.
[11] M. Hjermstad,et al. Assessment and classification of cancer breakthrough pain: A systematic literature review , 2010, PAIN.
[12] M. Bennett. Cancer pain terminology: Time to develop a taxonomy that promotes good clinical practice and allows research to progress , 2010, PAIN.
[13] K. Foley,et al. Types and epidemiology of cancer-related neuropathic pain: the intersection of cancer pain and neuropathic pain. , 2010, The oncologist.
[14] J. Farrar,et al. Assessment of cancer-related neuropathy and neuropathic pain. , 2010, The oncologist.
[15] Cinzia Brunelli,et al. Comparison of numerical and verbal rating scales to measure pain exacerbations in patients with chronic cancer pain , 2010, Health and quality of life outcomes.
[16] E. Zecca,et al. The validity of average 8‐h pain intensity assessment in cancer patients , 2010, European journal of pain.
[17] J. Farrar,et al. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders. , 2010, The journal of pain : official journal of the American Pain Society.
[18] T. Mok,et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. , 2009, The New England journal of medicine.
[19] C. Brunelli,et al. Comparison between numerical rating scale and six-level verbal rating scale in cancer patients with pain: a preliminary report , 2009, Supportive Care in Cancer.
[20] R. Melzack,et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2) , 2009, PAIN®.
[21] S. Mercadante,et al. Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. , 2009, The journal of pain : official journal of the American Pain Society.
[22] C. Reid,et al. The management of cancer‐related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland , 2009, European journal of pain.
[23] Bhupendra Rawal,et al. A Novel Tool for the Assessment of Pain: Validation in Low Back Pain , 2009, PLoS medicine.
[24] G. Cruccu,et al. Tools for Assessing Neuropathic Pain , 2009, PLoS medicine.
[25] M. Hjermstad,et al. Classification of pain in cancer patients – a systematic literature review , 2009, Palliative medicine.
[26] A. Abernethy,et al. A framework for generalizability in palliative care. , 2009, Journal of pain and symptom management.
[27] M. Hjermstad,et al. Assessment and classification of cancer pain , 2009, Current opinion in supportive and palliative care.
[28] A. Fairchild,et al. Is pain intensity a predictor of the complexity of cancer pain management? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Sharon M. Watanabe,et al. The Edmonton symptom assessment system—what do patients think? , 2009, Supportive Care in Cancer.
[30] D. Cella,et al. Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization , 2008, Quality of Life Research.
[31] M. Hjermstad,et al. Pain assessment tools in palliative care: an urgent need for consensus , 2008, Palliative medicine.
[32] Dagny Faksvåg Haugen,et al. Symptom assessment in palliative care: a need for international collaboration. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] P. Selby,et al. The clinical value of quality of life assessment in oncology practice—a qualitative study of patient and physician views , 2008, Psycho-oncology.
[34] A. Stubhaug,et al. Assessment of pain. , 2008, British journal of anaesthesia.
[35] R. Fainsinger,et al. Global warming in the palliative care research environment – adapting to change , 2008, Palliative medicine.
[36] S. Kaasa. Editorial: Palliative care research – time to intensify international collaboration , 2008, Palliative medicine.
[37] J. Dostrovsky,et al. Neuropathic pain , 2008, Neurology.
[38] R. Fainsinger,et al. A “TNM” classification system for cancer pain: The Edmonton Classification System for Cancer Pain (ECS-CP) , 2008, Supportive Care in Cancer.
[39] S. Lydersen,et al. The Brief Pain Inventory: Pain's Interference With Functions Is Different in Cancer Pain Compared With Noncancer Chronic Pain , 2008, The Clinical journal of pain.
[40] Sharon M. Watanabe,et al. The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991–2006) , 2008, Palliative medicine.
[41] D. Tibboel,et al. Comparison of different pain scoring systems in critically ill patients in a general ICU , 2008, Critical care.
[42] R. Fainsinger,et al. The Alberta Breakthrough Pain Assessment Tool for cancer patients: a validation study using a delphi process and patient think-aloud interviews. , 2008, Journal of pain and symptom management.
[43] M. Maltoni. Opioids, pain, and fear. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[44] Jay R Thomas. Optimizing opioid management in palliative care. , 2007, Journal of palliative medicine.
[45] C. Cleeland. Symptom burden: multiple symptoms and their impact as patient-reported outcomes. , 2007, Journal of the National Cancer Institute. Monographs.
[46] H C Schouten,et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[47] Nan Rothrock,et al. Evaluation of Item Candidates: The PROMIS Qualitative Item Review , 2007, Medical care.
[48] S. Kaasa,et al. Can cancer patients assess the influence of pain on functions? A randomised, controlled study of the pain interference items in the Brief Pain Inventory , 2007, BMC palliative care.
[49] M. Bennett,et al. Using screening tools to identify neuropathic pain , 2007, PAIN.
[50] M. Hjermstad,et al. Methodological and structural challenges in palliative care research: how have we fared in the last decades? , 2006, Palliative medicine.
[51] Augusto Caraceni,et al. Pain assessment tools: is the content appropriate for use in palliative care? , 2006, Journal of pain and symptom management.
[52] B. Galer,et al. The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome. , 2006, The journal of pain : official journal of the American Pain Society.
[53] E. Zecca,et al. Enhancing the quality of clinical trials in cancer pain first requires that pain assessment methods are appropriately understood and used , 2006, British Journal of Cancer.
[54] R. Baron,et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain , 2006, Current medical research and opinion.
[55] G. Hruby,et al. Mild, moderate, or severe pain categorized by patients with cancer with bone metastases. , 2006, Journal of palliative medicine.
[56] R. Portenoy. Development and testing of a neuropathic pain screening questionnaire: ID Pain , 2006, Current medical research and opinion.
[57] Mellar P. Davis,et al. Cancer symptom assessment instruments: a systematic review. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] W. Stalman,et al. Defining the patient population: one of the problems for palliative care research , 2006, Palliative medicine.
[59] M. Maltoni,et al. Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients , 2006, Health and quality of life outcomes.
[60] M. Echteld,et al. EORTC QLQ-C15-PAL: the new standard in the assessment of health-related quality of life in advanced cancer? , 2006, Palliative medicine.
[61] R. Fainsinger,et al. A validation study of a pain classification system for advanced cancer patients using content experts: the Edmonton Classification System for Cancer Pain , 2005, Palliative medicine.
[62] E. Zecca,et al. Cancer pain assessment in clinical trials. A review of the literature (1999-2002). , 2005, Journal of pain and symptom management.
[63] S. Fishman,et al. Consensus panel recommendations for the assessment and management of breakthrough pain parr I assessment , 2005 .
[64] E. Kalso,et al. Breakthrough pain in malignant and non‐malignant diseases: a review of prevalence, characteristics and mechanisms , 2005, European journal of pain.
[65] A. Vigano,et al. A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients. , 2005, Journal of pain and symptom management.
[66] Bernard Laurent,et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) , 2005, Pain.
[67] Blair H. Smith,et al. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. , 2005, The journal of pain : official journal of the American Pain Society.
[68] K. Grafton,et al. Test-Retest Reliability of the Short-Form McGill Pain Questionnaire: Assessment of Intraclass Correlation Coefficients and Limits of Agreement in Patients With Osteoarthritis , 2005, The Clinical journal of pain.
[69] J. Farrar,et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.
[70] J. Unützer,et al. National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. , 2004 .
[71] T Philip,et al. International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[72] Jacques Fermanian,et al. Development and validation of the Neuropathic Pain Symptom Inventory , 2004, Pain.
[73] M. Groenvold,et al. Pain characteristics and treatment outcome for advanced cancer patients during the first week of specialized palliative care. , 2004, Journal of pain and symptom management.
[74] Misha-Miroslav Backonja,et al. Development of a Neuropathic Pain Questionnaire , 2003, The Clinical journal of pain.
[75] Misha-Miroslav Backonja,et al. Neuropathic Pain Questionnaire—Short Form , 2003, The Clinical journal of pain.
[76] I. Higginson,et al. Identifying neuropathic pain in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale. , 2003, Journal of the Royal Society of Medicine.
[77] D. Walsh,et al. A prospective study of the pathophysiology and clinical characteristics of pain in a palliative medicine population , 2003, The American journal of hospice & palliative care.
[78] M. Jensen,et al. The validity and reliability of pain measures in adults with cancer. , 2003, The journal of pain : official journal of the American Pain Society.
[79] B. Kasimis,et al. Cancer breakthrough pain characteristics and responses to treatment at a VA medical center , 2003, Pain.
[80] J. Unützer,et al. National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. , 2004, Journal of the National Cancer Institute. Monographs.
[81] J. Ware. SF-36 health survey: Manual and interpretation guide , 2003 .
[82] D. Fairclough,et al. Development of a cancer pain prognostic scale. , 2002, Journal of pain and symptom management.
[83] Harald Breivik,et al. International Association for the Study of Pain: update on WHO-IASP activities. , 2002, Journal of pain and symptom management.
[84] F. Fulfaro,et al. Pain Mechanisms Involved and Outcome in Advanced Cancer Patients with Possible Indications for Celiac Plexus Block and Superior Hypogastric Plexus Block , 2002, Tumori.
[85] Augusto Caraceni,et al. Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. , 2002, Journal of pain and symptom management.
[86] S. Kaasa,et al. Episodic (breakthrough) pain , 2002, Cancer.
[87] A. Caraceni,et al. Classification of cancer pain syndromes. , 2001, Oncology.
[88] A. Caraceni. Evaluation and assessment of cancer pain and cancer pain treatment , 2001, Acta anaesthesiologica Scandinavica.
[89] L. Radbruch,et al. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology , 2001, Pain.
[90] J. Chibnall,et al. Pain assessment in cognitively impaired and unimpaired older adults: a comparison of four scales , 2001, Pain.
[91] M. Bennett,et al. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs , 2001, Pain.
[92] S. Collins,et al. Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice , 2001, Palliative Medicine.
[93] R. Lennard,et al. The prevalence of episodic pain in cancer: a survey of hospice patients on admission , 2001, Palliative medicine.
[94] Ronald Melzack,et al. The McGill Pain Questionnaire: Appraisal and current status. , 2001 .
[95] C. Cleeland,et al. Assessing symptom distress in cancer patients , 2000 .
[96] F. Hasson,et al. Research guidelines for the Delphi survey technique. , 2000, Journal of advanced nursing.
[97] H. Thaler,et al. The Memorial Symptom Assessment Scale Short Form (MSAS‐SF) , 2000, Cancer.
[98] F. Fulfaro,et al. Opioid responsiveness-primary diagnosis relationship in advanced cancer patients followed at home. , 2000, Journal of pain and symptom management.
[99] F. Fulfaro,et al. Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender , 2000, Supportive Care in Cancer.
[100] C. Cleeland,et al. Validation of the German version of the Brief Pain Inventory. , 1999, Journal of pain and symptom management.
[101] A. Caraceni,et al. An international survey of cancer pain characteristics and syndromes , 1999, PAIN.
[102] Paul Jacobsen,et al. Breakthrough pain: characteristics and impact in patients with cancer pain , 1999, Pain.
[103] S. Mercadante. Opioid responsiveness in patients with advanced head and neck cancer , 1998, Supportive Care in Cancer.
[104] M. Groenvold,et al. Guidelines for developing questionnaire modules: EORTC quality of life study group , 1998 .
[105] G. Hanks,et al. ABC of palliative care: Difficult pain problems , 1997 .
[106] E. Bruera,et al. Severe opioid toxicity and somatization of psychosocial distress in a cancer patient with a background of chemical dependence. , 1997, Journal of pain and symptom management.
[107] B. Galer,et al. Development and preliminary validation of a pain measure specific to neuropathic pain , 1997, Neurology.
[108] A. Feinstein,et al. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer , 1996, Cancer.
[109] L. Radbruch,et al. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service , 1996, Pain.
[110] S. R. Cohen,et al. Opioid use in advanced malignant disease: why do different centers use vastly different doses? A plea for standardized reporting. , 1995, Journal of pain and symptom management.
[111] E. Bruera,et al. A prospective multicenter assessment of the Edmonton staging system for cancer pain. , 1995, Journal of pain and symptom management.
[112] S. Mercadante,et al. Pain characteristics of advanced lung cancer patients referred to a palliative care service , 1994, Pain.
[113] C. Cleeland,et al. Pain and its treatment in outpatients with metastatic cancer. , 1994, The New England journal of medicine.
[114] W. David Leak,et al. Handbook of Pain Assessment , 1994 .
[115] J. V. Von Roenn,et al. Physician Attitudes and Practice in Cancer Pain Management: A Survey From the Eastern Cooperative Oncology Group , 1993, Annals of Internal Medicine.
[116] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[117] D. Tulsky,et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[118] S. Mercadante,et al. Predictive factors in advanced cancer pain treated only by analgesics , 1992, Pain.
[119] A. Caraceni,et al. Cancer pain classification: a controversial issue , 1991, Pain.
[120] Eduardo Bruera,et al. The Edmonton Symptom Assessment System (ESAS): A Simple Method for the Assessment of Palliative Care Patients , 1991, Journal of palliative care.
[121] J. de Haes,et al. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. , 1990, British Journal of Cancer.
[122] R. Portenoy,et al. Breakthrough pain: definition, prevalence and characteristics , 1990, Pain.
[123] E. Bruera,et al. The Edmonton staging system for cancer pain: preliminary report , 1989, Pain.
[124] A. Bassols,et al. Acceptability of visual analogue scales in the clinical setting: a comparison with verbal rating scales in postoperative pain. , 1989, Methods and findings in experimental and clinical pharmacology.
[125] P. Wall,et al. Textbook of pain , 1989 .
[126] Ronald Melzack,et al. The short-form McGill pain questionnaire , 1987, Pain.
[127] van Dam Fs,et al. Pain in cancer , 1986 .
[128] S. Arnér,et al. Differential Effects of Epidural Morphine in the Treatment of Cancer‐related Pain , 1985, Acta anaesthesiologica Scandinavica.
[129] A McMurray,et al. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[130] C. Cleeland,et al. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases , 1983, Pain.
[131] J. Bonica,et al. Editorial The need of a taxonomy , 1979, PAIN.
[132] R. Melzack. The McGill Pain Questionnaire: Major properties and scoring methods , 1975, PAIN.
[133] J. Sloan,et al. Genetics and the quality of life. , 2006, Study encounter.
[134] M. E. Perkins. FIELD STUDIES IN THE MENTAL DISORDERS , 1962 .